Literature DB >> 24463425

Ocular vestibular-evoked myogenic potentials (oVEMP) to skull taps in normal and dehiscent ears: mechanisms and markers of superior canal dehiscence.

Rachael L Taylor1, Catherine Blaivie, Andreas P Bom, Berit Holmeslet, Tony Pansell, Krister Brantberg, Miriam S Welgampola.   

Abstract

The site of stimulus delivery modulates the waveforms of cervical- and ocular vestibular-evoked myogenic potentials (cVEMP and oVEMP) to skull taps in healthy controls. We examine the influence of stimulus location on the oVEMP waveforms of 18 patients (24 ears) with superior canal dehiscence (SCD) and compare these with the results of 16 healthy control subjects (32 ears). oVEMPs were recorded in response to taps delivered with a triggered tendon-hammer and a hand-held minishaker at three midline locations; the hairline (Fz), vertex (Cz) and occiput (Oz). In controls, Fz stimulation evoked a consistent oVEMP waveform with a negative peak (n1) at 9.5 ± 0.5 ms. In SCD, stimulation at Fz produced large oVEMP waveforms with delayed n1 peaks (tendon-hammer = 13.2 ± 1.0 ms and minitap = 11.5 ± 1.1 ms). Vertex taps produced diverse low-amplitude waveforms in controls with n1 peaks at 15.5 ± 1.2 and 13.2 ± 1.3 ms for tendon-hammer taps and minitaps, respectively; in SCD, they produced large amplitude oVEMP waveforms with n1 peaks at 12.9 ± 0.8 ms (tendon-hammer) and 12.1 ± 0.5 ms (minitap). Occiput stimulation evoked oVEMPs with similar n1 latencies in both groups (tendon-hammer = 11.3 ± 1.3 and 10.7 ± 0.8; minitap = 10.3 ± 0.9 and 11.1 ± 0.4 for control and SCD ears, respectively). Compared to reflex amplitudes, n1 peak latencies to Fz taps provided clearer separation between SCD and control ears. The distinctly different effects of Fz and vertex taps on the oVEMP waveforms may represent an additional non-osseous mechanism of stimulus transmission in SCD. For skull taps at Fz, a prolonged n1 latency is an indicator of SCD.

Entities:  

Mesh:

Year:  2014        PMID: 24463425     DOI: 10.1007/s00221-013-3782-z

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  31 in total

1.  Ocular vestibular evoked myogenic potentials: skull taps can cause a stimulus direction dependent double-peak.

Authors:  Berit Holmeslet; Magnus Westin; Krister Brantberg
Journal:  Clin Neurophysiol       Date:  2010-07-27       Impact factor: 3.708

2.  Head taps evoke a crossed vestibulo-ocular reflex.

Authors:  S Iwasaki; L A McGarvie; G M Halmagyi; A M Burgess; J Kim; J G Colebatch; I S Curthoys
Journal:  Neurology       Date:  2007-04-10       Impact factor: 9.910

3.  Ocular vestibular evoked myogenic potentials (OVEMPs) produced by air- and bone-conducted sound.

Authors:  Neil P McAngus Todd; Sally M Rosengren; Swee T Aw; James G Colebatch
Journal:  Clin Neurophysiol       Date:  2006-12-01       Impact factor: 3.708

4.  Single motor unit activity in human extraocular muscles during the vestibulo-ocular reflex.

Authors:  Konrad P Weber; Sally M Rosengren; Rike Michels; Veit Sturm; Dominik Straumann; Klara Landau
Journal:  J Physiol       Date:  2012-04-23       Impact factor: 5.182

5.  Sound- and/or pressure-induced vertigo due to bone dehiscence of the superior semicircular canal.

Authors:  L B Minor; D Solomon; J S Zinreich; D S Zee
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-03

6.  Ocular vestibular evoked myogenic potentials in superior canal dehiscence.

Authors:  S M Rosengren; S T Aw; G M Halmagyi; N P McAngus Todd; J G Colebatch
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-31       Impact factor: 10.154

7.  Ocular vestibular evoked myogenic potentials via bone-conducted vibrations applied to various midsagittal cranial sites.

Authors:  Chi-Maw Lin; Shou-Jen Wang; Yi-Ho Young
Journal:  Otol Neurotol       Date:  2010-01       Impact factor: 2.311

8.  Pulse-synchronous eye oscillations revealing bone superior canal dehiscence.

Authors:  Caroline Tilikete; Pierre Krolak-Salmon; Eric Truy; Alain Vighetto
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

9.  Ocular vestibular evoked myogenic potentials to bone conducted vibration of the midline forehead at Fz in healthy subjects.

Authors:  S Iwasaki; Y E Smulders; A M Burgess; L A McGarvie; H G Macdougall; G M Halmagyi; I S Curthoys
Journal:  Clin Neurophysiol       Date:  2008-07-17       Impact factor: 3.708

10.  The Tullio phenomenon: a neurologically neglected presentation.

Authors:  Diego Kaski; R Davies; L Luxon; A M Bronstein; P Rudge
Journal:  J Neurol       Date:  2011-07-09       Impact factor: 4.849

View more
  5 in total

Review 1.  Clinical utility of ocular vestibular-evoked myogenic potentials (oVEMPs).

Authors:  Konrad P Weber; Sally M Rosengren
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

2.  Assessment of otolith function using vestibular evoked myogenic potential in women during pregnancy.

Authors:  G Bhavana; Kaushlendra Kumar; E Anupriya
Journal:  Braz J Otorhinolaryngol       Date:  2020-09-28

3.  Optimization of Cervical and Ocular Vestibular Evoked Myogenic Potential Testing Using an Impulse Hammer in Adults, Adolescents, and Children.

Authors:  Amanda I Rodriguez; Elizabeth Marler; Denis Fitzpatrick; Thomas Creutz; Shauntelle A Cannon; Megan L A Thomas; Kristen L Janky
Journal:  Otol Neurotol       Date:  2020-07       Impact factor: 2.619

Review 4.  The Contributions of Vestibular Evoked Myogenic Potentials and Acoustic Vestibular Stimulation to Our Understanding of the Vestibular System.

Authors:  Sally M Rosengren; James G Colebatch
Journal:  Front Neurol       Date:  2018-06-29       Impact factor: 4.003

5.  Bone-Conducted oVEMP Latency Delays Assist in the Differential Diagnosis of Large Air-Conducted oVEMP Amplitudes.

Authors:  Rachael L Taylor; John S Magnussen; Belinda Kwok; Allison S Young; Berina Ihtijarevic; Emma C Argaet; Nicole Reid; Cheryl Rivas; Jacob M Pogson; Sally M Rosengren; G Michael Halmagyi; Miriam S Welgampola
Journal:  Front Neurol       Date:  2020-10-29       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.